scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9378(99)70026-8 |
P698 | PubMed publication ID | 10368478 |
P2093 | author name string | E F Magann | |
J N Martin | |||
P G Blake | |||
W L May | |||
B K Rinehart | |||
D A Terrone | |||
P2860 | cites work | Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy | Q33350552 |
HELLP syndrome--a syndrome of hemolysis, elevated liver enzymes and low platelet count--complicating preeclampsia-eclampsia. | Q33371904 | ||
The natural history of HELLP syndrome: patterns of disease progression and regression | Q33389693 | ||
Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? | Q33398720 | ||
The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? | Q33404012 | ||
Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy | Q33484095 | ||
Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). | Q33491030 | ||
Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). | Q33496080 | ||
Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome | Q33501062 | ||
The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification | Q33864822 | ||
Urinary dipstick protein: a poor predictor of absent or severe proteinuria | Q34348840 | ||
Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. | Q34393266 | ||
Upper abdominal pain in pregnancy may indicate pre-eclampsia | Q36886075 | ||
HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) presenting as generalized malaise | Q40543123 | ||
The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. | Q40809291 | ||
Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome | Q46358525 | ||
Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) | Q46363621 | ||
Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome | Q72336105 | ||
Acute intravascular hemolysis and lower nephron nephrosis complicating eclampsia | Q80718295 | ||
P433 | issue | 6 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 1407-1414 | |
P577 | publication date | 1999-06-01 | |
P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
P1476 | title | Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity | |
P478 | volume | 180 |
Q27003730 | A brief overview of preeclampsia |
Q44047707 | Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia |
Q33830864 | Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review |
Q33237268 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. |
Q92999663 | Acute Liver Failure (ALF) in Pregnancy: How Much Is Pregnancy-Related? |
Q37970942 | Admission uric acid levels and length of expectant management in preterm preeclampsia |
Q34039254 | Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology |
Q46342652 | Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti |
Q33579089 | Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013). |
Q46251412 | Does uric acid provide information about maternal condition and fetal outcome in pregnant women with hypertension? |
Q33421540 | Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review |
Q33334624 | HELLP syndrome |
Q33830857 | How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis |
Q42961023 | Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia |
Q35840397 | Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia |
Q36725777 | Litigation in obstetrics: a lesson learnt and a lesson to share |
Q34224924 | Management and monitoring of severe preeclampsia |
Q44606804 | Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome |
Q46355973 | Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome |
Q43297926 | Optimal laboratory panel for predicting preeclampsia. |
Q37770575 | Options and decision-making: hypertensive disorders of pregnancy |
Q34119026 | Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study |
Q34079933 | Pre-eclampsia |
Q36327393 | Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models |
Q39238730 | Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy |
Q58740073 | Pregnancy-Related ICU Admissions From 2008 to 2016 in China: A First Multicenter Report |
Q43941165 | Prevalence of hypertensive disorders in a prenatal clinic in Zanzibar |
Q38594110 | SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. |
Q41852771 | Specialized Diagnostic Investigations to Assess Ocular Status in Hypertensive Diseases of Pregnancy |
Q46348174 | The Importance of Parity to Major Maternal Morbidity in the Eclamptic Mother with Hellp Syndrome |
Q33930523 | The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community |
Q37186201 | Uric acid: is it time to give up routine testing in management of pre-eclampsia? |
Q33994227 | Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study |